• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发肿瘤、播散性肿瘤细胞和显转移之间的遗传差异。

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.

机构信息

Department of General, Visceral, and Pediatric Surgery, Heinrich-Heine-University and University Hospital Düsseldorf, D-40225 Düsseldorf, Germany.

出版信息

Int J Cancer. 2010 Feb 1;126(3):589-98. doi: 10.1002/ijc.24916.

DOI:10.1002/ijc.24916
PMID:19795462
Abstract

Recent genetic analyses of paired samples from primary tumours and disseminated tumour cells have uncovered a bewildering genetic disparity. It was therefore proposed that ectopically residing tumour cells disseminate early and develop independently into metastases parallel to the primary tumour. Alternatively, these cells may represent an irrelevant cell population unable to spawn metastases whereas only cells that disseminated late in primary tumour development (which therefore are similar to the primary tumour) will form manifest metastasis. Here, we review comparative analyses of paired samples from primary tumours and disseminated tumour cells or primary tumours and metastases. The data demonstrate a striking disparity, questioning the use of primary tumours as surrogate for the genetics of systemic cancer. In the era of molecular therapies that build upon genetic defects of tumour cells, these data call for a direct diagnostic pathology of systemic cancer.

摘要

最近对原发性肿瘤和播散性肿瘤细胞配对样本的遗传分析揭示了令人困惑的遗传差异。因此,有人提出异位肿瘤细胞早期播散,并与原发性肿瘤平行独立地发展为转移。或者,这些细胞可能代表一种无关的细胞群体,无法产生转移,而只有在原发性肿瘤发展后期播散的细胞(因此与原发性肿瘤相似)才会形成明显的转移。在这里,我们回顾了原发性肿瘤和播散性肿瘤细胞或原发性肿瘤和转移瘤配对样本的比较分析。这些数据显示出明显的差异,质疑将原发性肿瘤作为系统性癌症遗传的替代物的做法。在基于肿瘤细胞遗传缺陷的分子治疗时代,这些数据呼吁对系统性癌症进行直接的诊断病理学研究。

相似文献

1
Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.原发肿瘤、播散性肿瘤细胞和显转移之间的遗传差异。
Int J Cancer. 2010 Feb 1;126(3):589-98. doi: 10.1002/ijc.24916.
2
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.微小残留癌中单个播散肿瘤细胞的遗传异质性
Lancet. 2002 Aug 31;360(9334):683-9. doi: 10.1016/S0140-6736(02)09838-0.
3
[From single disseminated tumor cells to metastasis insights from molecular genetic analyses of single cells].[从单个播散肿瘤细胞到转移:单细胞分子遗传学分析的见解]
Verh Dtsch Ges Pathol. 2003;87:158-64.
4
Parallel progression of primary tumours and metastases.原发性肿瘤和转移灶的平行进展。
Nat Rev Cancer. 2009 Apr;9(4):302-12. doi: 10.1038/nrc2627.
5
Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.从乳腺癌患者血液中纯化的微小残留癌细胞中基因组改变的预后价值。
Br J Cancer. 2000 Dec;83(12):1664-73. doi: 10.1054/bjoc.2000.1501.
6
[Direct molecular analysis of single disseminated cancer cells: a prerequisite for the development of adjuvant therapies?].
Acta Med Austriaca Suppl. 2002;59:10-3.
7
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.EO771.LMB肿瘤的功能和分子特征,一种新的源自C57BL/6小鼠的自发性转移性乳腺癌模型。
Dis Model Mech. 2015 Mar;8(3):237-51. doi: 10.1242/dmm.017830. Epub 2015 Jan 29.
8
The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.p53、bcl-2、bax、fas和fasL在乳腺癌原发肿瘤及淋巴结转移灶中的表达
Acta Oncol. 2009;48(8):1137-43. doi: 10.3109/02841860902988688.
9
Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.循环肿瘤细胞的分子表型分析在前列腺癌患者中的应用:对远处转移的预测。
BJU Int. 2012 Dec;110(11 Pt C):E1202-11. doi: 10.1111/j.1464-410X.2012.11534.x. Epub 2012 Oct 9.
10
The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.乳腺癌转移前体细胞的直接分子分析:更好理解转移及实现个性化医疗的契机
Eur J Cancer. 2008 Dec;44(18):2721-5. doi: 10.1016/j.ejca.2008.09.035. Epub 2008 Nov 18.

引用本文的文献

1
Clinical Tumor Dormancy.临床肿瘤休眠
Methods Mol Biol. 2024;2811:1-26. doi: 10.1007/978-1-0716-3882-8_1.
2
Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside.当代小儿横纹肌肉瘤临床前小鼠模型:从床边到实验台再回到床边
Front Oncol. 2024 Feb 2;14:1333129. doi: 10.3389/fonc.2024.1333129. eCollection 2024.
3
Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients.从乳腺癌患者骨髓中微流控分离循环肿瘤细胞
Int J Mol Sci. 2023 Sep 11;24(18):13930. doi: 10.3390/ijms241813930.
4
The different clonal origins of metachronous and synchronous metastases.不同克隆起源的异时性和同时性转移。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11085-11092. doi: 10.1007/s00432-023-05007-3. Epub 2023 Jun 20.
5
Significance of circulating tumor cells in lung cancer: a narrative review.循环肿瘤细胞在肺癌中的意义:一篇叙述性综述。
Transl Lung Cancer Res. 2023 Apr 28;12(4):877-894. doi: 10.21037/tlcr-22-712. Epub 2023 Mar 29.
6
The Impact of YRNAs on HNSCC and HPV Infection.YRNAs对头颈部鳞状细胞癌和人乳头瘤病毒感染的影响。
Biomedicines. 2023 Feb 23;11(3):681. doi: 10.3390/biomedicines11030681.
7
The genomic regulation of metastatic dormancy.转移性休眠的基因组调控。
Cancer Metastasis Rev. 2023 Mar;42(1):255-276. doi: 10.1007/s10555-022-10076-w. Epub 2023 Jan 5.
8
Diabetogenic liver metastasis from pancreatic cancer: a case report.胰腺癌导致糖尿病的肝转移:一例报告
Surg Case Rep. 2022 Dec 28;8(1):224. doi: 10.1186/s40792-022-01582-8.
9
Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance.黑色素瘤:分子遗传学、转移、靶向治疗、免疫治疗及治疗耐药性
Genes Dis. 2022 Apr 27;9(6):1608-1623. doi: 10.1016/j.gendis.2022.04.004. eCollection 2022 Nov.
10
Patterns of metastases progression- The linear parallel ratio.转移进展模式——线性平行比。
PLoS One. 2022 Sep 21;17(9):e0274942. doi: 10.1371/journal.pone.0274942. eCollection 2022.